Endocrinology
-
Prenatal PFAS Exposure Linked to Lifelong Diabetes Risk: Detox Diets Emerge as Mitigation Strategy
New research reveals prenatal PFAS exposure impairs pancreatic beta cells, increasing diabetes risk. Experts critique regulatory gaps while advocating detox foods like cilantro and chlorella.…
-
Prenatal PFAS Exposure Linked to Long-Term Maternal Metabolic Dysfunction, New 2024 Study Reveals
A May 2024 study in *Environmental Health Perspectives* connects prenatal PFAS exposure to impaired maternal beta cell function, while new EPA regulations and EU reports…
-
Prenatal PFAS Exposure Linked to Lifelong Metabolic Dysfunction, New Studies Reveal
June 2024 research demonstrates prenatal PFAS exposure disrupts pancreatic beta cell function, increasing diabetes risk. EFSA slashes safety limits by 80% as EWG urges pregnancy…
-
Prenatal PFAS exposure linked to maternal beta cell dysfunction and increased diabetes risk
New research reveals prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk, with significant socioeconomic disparities in exposure levels. Recent studies show prenatal…
-
Prenatal PFAS exposure linked to long-term metabolic dysfunction, new studies reveal
Recent research shows prenatal PFAS exposure correlates with beta cell dysfunction and metabolic disorders, prompting calls for stricter regulations and exposure reduction strategies. Emerging studies…
-
Prenatal PFAS exposure linked to maternal beta cell dysfunction and increased diabetes risk
New research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing gestational diabetes risk by 30%, with long-term metabolic consequences. Emerging evidence reveals PFAS…
-
Prenatal PFAS exposure linked to long-term maternal beta cell dysfunction, new study reveals
Recent research shows prenatal PFAS exposure disrupts maternal beta cell function, increasing diabetes risk years after pregnancy, with significant public health implications. Groundbreaking study reveals…
-
Prenatal PFAS exposure linked to long-term maternal beta cell dysfunction, study finds
New research reveals prenatal PFAS exposure may impair maternal beta cell function long-term, increasing diabetes risk amid widespread contamination concerns. Groundbreaking study connects prenatal PFAS…
-
Prenatal PFAS exposure linked to 34% reduction in maternal HOMA-β, new study reveals
New research shows prenatal PFAS exposure reduces maternal HOMA-β by 34%, with epigenetic and oxidative stress markers providing mechanistic insights. Global regulatory responses are evolving.…
-
Combined autoantibody screening revolutionizes LADA diagnosis in type 2 diabetes patients
New research shows combined GADA, ICA, and IAA testing identifies 10% of type 2 diabetes cases as LADA, with significant treatment implications. Groundbreaking studies reveal…